Back
to sessions
Sep 28
Quick Pitch
Credits
| AMA PRA Category 1 Credits: | 1.00 |
Presentations
-
08:00am - 08:05am ETSpeaker: Neil Newman, MD, MS - Home, San Antonio
-
08:05am - 08:10am ET
A Prospective Study of Adaptive MRI-Guided Dose-Escalated Radiation Therapy for Locally Advanced Rectal Cancer
Speaker: Russell Palm, MD - The Ohio State University James Cancer Hospital, Columbus -
08:10am - 08:15am ET
Neoadjuvant Chemoradiotherapy with Modern Bowel-Sparing IMRT for Locally Advanced Rectal Cancer: A Multi-Institutional Phase II Trial
Speaker: Katsuyuki Sakanaka, MD, PhD - Kyoto University Hospital, Kyoto -
08:15am - 08:20am ET
Distinct Efficacy between Very Early-Onset Locally Advanced Rectal Cancer (VEO-LARC) and Late-Onset LARC Receiving Total Neoadjuvant Therapy with or without Immunotherapy
Speaker: Mingxu Yan, MD - Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai -
08:20am - 08:25am ET
CXCL12-Driven Anti-Tumor Neutrophil Infiltration Predicts Pathological Complete Response in pMMR Rectal Cancer Treated with Neoadjuvant SCRT and PD-1 Blockade
Speaker: Meng He, MD, PhD - National Cancer Center/National Clinical Research Center for Cancer Cancer Hospital, CAMS & PUMC, Beijing -
08:25am - 08:30am ET
Tumor-Informed Circulating Tumor DNA for Prediction of Organ Preservation and Enhanced Surveillance in Locally Advanced Rectal Cancer: A Real-World Cohort
Speaker: Revathi Ravella, MD - Memorial Sloan Kettering Cancer Center, New York -
08:30am - 08:35am ET
Durability of Watch-and-Wait after Long- vs. Short-Course Radiation In Total Neoadjuvant Therapy for Rectal Cancer
Speaker: Revathi Ravella, MD - Memorial Sloan Kettering Cancer Center, New York -
08:35am - 08:55am ETSpeaker: Erqi Pollom, MD, MS - Stanford Cancer Institute Palo Alto, Stanford
-
08:55am - 09:00am ETSpeaker: Neil Newman, MD, MS - Home, San Antonio